Consensus Caplin Point Laboratories Limited NSE India S.E.

Equities

CAPLIPOINT

INE475E01026

Delayed NSE India S.E. Other stock markets 06:02:42 2024-05-06 am EDT			5-day change	1st Jan Change
1,309 ^INR	+0.80%		-3.38%	-4.14%

08:19am	Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	MT
Apr. 16	Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	MT

Evolution of the average Target Price on Caplin Point Laboratories Limited

Price target over the last 5 years

History of analyst recommendation changes

278ff21da8c3cdbfefeca784.dyrs6Bsj8ZGXBts0Bvg8vqP1I3NN-xTSlNnL9zSKPyU.QlmfgHRIqNj_NY91MJlQ_PTFehQ3jlOZ_IO5kFHER18lSIqiS3vA9uY34w~2374c173f4ca5c638f8a82f41f1bd5be

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,299 INR

Average target price

1,579 INR

Spread / Average Target

+21.60%

High Price Target

1,660 INR

Spread / Highest target

+27.81%

Low Price Target

1,535 INR

Spread / Lowest Target

+18.19%

Consensus detail

Consensus revision (last 18 months)

Ratings for Caplin Point Laboratories Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar